Come up with a name for your new list and we'll add to it:
Vivreon Biosciences raised a round of funding on August 16, 2017. Investors include
National Institute of Aging.
Vivreon Biosciences is a pre-clinical therapeutics company developing a new class of small molecule therapeutics for the treatment of chronic inflammatory diseases. The company's candidate therapies d…